INTIMATION OF VOTING RESULTS AND SCRUTINIZER REPORT
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics held a Tribunal Convened Meeting on August 12, 2025, via video conferencing to seek shareholder approval for the merger of Mangalam Laboratories Private Limited (MLPL) and Shri JB Pharma Private Limited (SJPPL) into the company. The resolution was passed as a Special Resolution with an overwhelming 6,139,430 votes (100%) in favor and only 25 votes against (0.00%). Public shareholders, voting separately as required under SEBI scheme rules, also backed the merger with 99.95% in favor (50,399 shares) versus just 0.05% against. The cut-off date for voting eligibility was August 5, 2025, with 20,081 total shareholders on record. Scrutinizer Venugopal Prasad Rao confirmed the resolution was duly passed with the requisite majority.
The merger scheme has cleared a key shareholder approval hurdle, which is positive for the stock. However, the merger still requires final sanction from the NCLT Mumbai Bench and other regulatory approvals before becoming effective, so completion timelines remain uncertain.